Dofequidar Fumarate (MS-209) in Combination With Cyclophosphamide, Doxorubicin, and Fluorouracil for Patients With Advanced or Recurrent Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Dofequidar Fumarate (MS-209) in Combination With Cyclophosphamide, Doxorubicin, and Fluorouracil for Patients With Advanced or Recurrent Breast Cancer

DOI Full Paper Access

80

Citations

20

References

2006

Year

Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi,

Journal of Clinical Oncology

Abstract

Dofequidar + CAF was well tolerated and is suggested to have efficacy in patients who had not received prior therapy.

References

	Year	Citations

Page 1